| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.7% | 72.6% | ▲ +1.9% |
| Healthcare Services | 15.9% | 18.3% | ▲ +2.4% |
| Retailing | 5.4% | 5.1% | ▼ -0.3% |
| Chemicals & Petrochemicals | 1.2% | 1.2% | ● 0.0% |
| Insurance | 1.1% | 1.1% | ● -0.1% |
| Healthcare Equipment & Supplies | 0.7% | 0.7% | ● +0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.6% | 67.3% | ▼ -5.3% |
| Healthcare Services | 18.3% | 20.4% | ▲ +2.2% |
| Retailing | 5.1% | 5.0% | ● -0.1% |
| IT - Services | 0.0% | 1.2% | ▲ +1.2% |
| Insurance | 1.1% | 1.0% | ● -0.1% |
| Chemicals & Petrochemicals | 1.2% | 0.9% | ▼ -0.3% |
| Healthcare Equipment & Supplies | 0.7% | 0.6% | ● -0.1% |
Comparing Sep 2026 → Oct 2026
| # | Stock | Sector | Weight (Oct 2026) |
|---|---|---|---|
| 1 | Sagility Limited ₹87.43 Cr |
IT - Services | 1.23% |
| # | Stock | Sector | Last Weight (Sep 2026) |
|---|---|---|---|
| 1 | Alivus Life Sciences ₹66.27 Cr |
Pharmaceuticals & Biotechnology | 0.97% |
| # | Stock | Sector | Sep 2026 | Oct 2026 | Change |
|---|---|---|---|---|---|
| 1 | Apollo Hospitals Enterprise Limited ₹333.20 Cr |
Healthcare Services | 2.30% | 4.69% | +2.39% |
| 2 | Indraprastha Medical Corporation Limited ₹59.01 Cr |
Healthcare Services | 0.47% | 0.83% | +0.36% |
| 3 | Natco Pharma Limited ₹26.44 Cr |
Pharmaceuticals & Biotechnology | 0.02% | 0.37% | +0.35% |
| 4 | Syngene International Limited ₹266.87 Cr |
Healthcare Services | 3.50% | 3.76% | +0.26% |
| 5 | AstraZeneca Pharma India Limited ₹141.10 Cr |
Pharmaceuticals & Biotechnology | 1.85% | 1.99% | +0.14% |
| 6 | Dr Agarwals Health Care Limited ₹196.82 Cr |
Healthcare Services | 2.66% | 2.77% | +0.11% |
| 7 | FDC Limited ₹50.76 Cr |
Pharmaceuticals & Biotechnology | 0.66% | 0.71% | +0.05% |
| 8 | Max Healthcare Institute Limited ₹189.36 Cr |
Healthcare Services | 2.63% | 2.67% | +0.04% |
| # | Stock | Sector | Sep 2026 | Oct 2026 | Change |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited ₹744.52 Cr |
Pharmaceuticals & Biotechnology | 11.49% | 10.48% | -1.01% |
| 2 | Divi's Laboratories Limited ₹219.49 Cr |
Pharmaceuticals & Biotechnology | 3.78% | 3.09% | -0.69% |
| 3 | Mankind Pharma Limited ₹319.41 Cr |
Pharmaceuticals & Biotechnology | 5.04% | 4.50% | -0.54% |
| 4 | Manipal Health Enterprises Ltd ₹29.52 Cr |
Healthcare Services | 0.87% | 0.42% | -0.45% |
| 5 | Gland Pharma Limited ₹111.19 Cr |
Pharmaceuticals & Biotechnology | 1.97% | 1.57% | -0.40% |
| 6 | Cohance Lifesciences Limited ₹260.66 Cr |
Pharmaceuticals & Biotechnology | 4.06% | 3.67% | -0.39% |
| 7 | Fine Organic Industries Limited ₹64.36 Cr |
Chemicals & Petrochemicals | 1.21% | 0.91% | -0.30% |
| 8 | Akums Drugs and Pharmaceuticals Limited ₹117.21 Cr |
Pharmaceuticals & Biotechnology | 1.91% | 1.65% | -0.26% |
| 9 | Abbott India Limited ₹164.99 Cr |
Pharmaceuticals & Biotechnology | 2.54% | 2.32% | -0.22% |
| 10 | Thyrocare Technologies Limited ₹68.48 Cr |
Healthcare Services | 1.17% | 0.96% | -0.21% |
39 stocks — Oct 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹744.52 Cr |
Pharmaceuticals & Biotechnology |
10.48%
|
|
| 2 |
₹685.13 Cr |
Pharmaceuticals & Biotechnology |
9.64%
|
|
| 3 |
₹410.62 Cr |
Pharmaceuticals & Biotechnology |
5.78%
|
|
| 4 |
₹376.20 Cr |
Pharmaceuticals & Biotechnology |
5.30%
|
|
| 5 |
₹333.20 Cr |
Healthcare Services |
4.69%
|
|
| 6 |
₹327.25 Cr |
Pharmaceuticals & Biotechnology |
4.61%
|
|
| 7 |
₹319.41 Cr |
Pharmaceuticals & Biotechnology |
4.50%
|
|
| 8 |
₹305.36 Cr |
Retailing |
4.30%
|
|
| 9 |
₹266.87 Cr |
Healthcare Services |
3.76%
|
|
| 10 |
₹260.66 Cr |
Pharmaceuticals & Biotechnology |
3.67%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.